Kolexia
Safar Violaine Hématologie
Safar Violaine
Hématologie
Hôpital Lyon Sud
Pierre-Bénite, France
82 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules Lymphome à cellules du manteau Lymphome T Maladie de Hodgkin Lymphome T périphérique Lymphome malin non hodgkinien Anémie

Collaborateurs

Voir plus
Bachy Emmanuel
Bachy Emmanuel
Hôpital Lyon Sud, Pierre-Bénite, France
Ghesquieres Herve
Ghesquieres Herve
Hôpital Lyon Sud, Pierre-Bénite, France
Salles Gilles
Salles Gilles
Hôpital Lyon Sud, Pierre-Bénite, France
Ferrant Emmanuelle
Ferrant Emmanuelle
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
BEIGENE
12 collaboration(s)
Dernière en 2023
Gilead
7 collaboration(s)
Dernière en 2023
Novartis
4 collaboration(s)
Dernière en 2021
Janssen
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LyMa101: Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
BRUIN-MCL-321: A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)
Essai Clinique (Loxo Oncology, Inc.)   24 janvier 2024
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   18 décembre 2023
Optical Genome Mapping Provides New Molecular Insights in High-Risk Mantle Cell Lymphoma: A Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
R-GemOx Plus Nivolumab Vs R-GemOx As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Interim Analysis of the Niveau Trial, an International, Randomized Phase 3 Study of the AGMT, GLA, HOVON, Lysa and PLRG
65th ASH Annual Meeting Abstracts   02 novembre 2023
Obinutuzumab Versus Rituximab in Transplant Eligible Untreated MCL Patients, a Matching Comparison between the Lyma and Lyma-101 Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
Induction and Maintenance Therapy in Elderly Patients with Mantle Cell Lymphoma: Double-Randomized MCL R2 Elderly Clinical Trial By the European Mantle Cell Lymphoma Network
65th ASH Annual Meeting Abstracts   02 novembre 2023
Validation of POD24 As a Robust Early Clinical End Point of Poor Survival in Mantle Cell Lymphoma from 1280 Patients on Clinical Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
Skeletal Muscle Index, As a Measure of Muscle Mass, Is a Significant Prognostic Factor for Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
Scientific reports   24 octobre 2023